FDA Approves BUPROPION HYDROCHLORIDE SR — Actavis Pharma, Inc.

Actavis Pharma, Inc. (Actavis) announced the approval of its generic Bupropion Hydrochloride SR tablets, entering a crowded market for smoking cessation and antidepressant therapies amid continued generic uptake. The designation as an ANDA allows the company to compete on cost, likely driving market share from higher-priced branded alternatives and placing pressure on Biovail Corporation’s Wellbutrin SR franchise.